Literature DB >> 17922020

EMT tumorigenesis in the mouse mammary gland.

Patrizia Damonte1, Jeffrey P Gregg, Alexander D Borowsky, Blaine A Keister, Robert D Cardiff.   

Abstract

The term EMT (epithelial-mesenchymal transition) is used in many settings. This term is used to describe the mechanisms facilitating cellular repositioning and redeployment during embryonic development and tissue reconstruction after injury. Recently, EMT has also been applied to potential mechanisms for malignant progression and has appeared as a specific diagnostic category of tumors. In mice, most 'EMT' tumors have a spindle cell phenotype. The definition of EMT is controversial because spindle cell tumors are not common in humans, especially in human breast cancers. Spindle cell tumors of the mouse mammary gland have been observed for many years where they are usually classified as sarcomas or carcinosarcomas. Genetically engineered mice develop mammary spindle cell tumors that appear to arise in the epithelium and undergo EMT. To better understand the origin and evolution of these spindle cell tumors in progression and metastases, seven cohorts of spindle cell tumors from the archives of the University of California, Davis Mutant Mouse Pathology Laboratory were studied. This study provides experimental and immunohistochemical evidence of EMT showing that dual epithelial and mesenchymal staining of tumor spindle cells identifies some, but not all, EMT-type tumors in the mouse. This suggests that potential EMT tumors are best designated EMT-phenotype tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922020      PMCID: PMC2754828          DOI: 10.1038/labinvest.3700683

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  29 in total

Review 1.  Epithelial-mesenchymal transitions in development and pathologies.

Authors:  Jean Paul Thiery
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

2.  Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.

Authors:  Edward J Gunther; Susan E Moody; George K Belka; Kristina T Hahn; Nathalie Innocent; Katherine D Dugan; Robert D Cardiff; Lewis A Chodosh
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

3.  Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.

Authors:  Luigi Strizzi; Caterina Bianco; Nicola Normanno; Masaharu Seno; Christian Wechselberger; Brenda Wallace-Jones; Nadia I Khan; Morihisa Hirota; Youping Sun; Michele Sanicola; David S Salomon
Journal:  J Cell Physiol       Date:  2004-11       Impact factor: 6.384

4.  Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.

Authors:  Ruria Namba; Jeannie E Maglione; Lawrence J T Young; Alexander D Borowsky; Robert D Cardiff; Carol L MacLeod; Jeffrey P Gregg
Journal:  Mol Cancer Res       Date:  2004-08       Impact factor: 5.852

5.  Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.

Authors:  Helenice Gobbi; Jean F Simpson; Roy A Jensen; Sandra J Olson; David L Page
Journal:  Mod Pathol       Date:  2003-09       Impact factor: 7.842

Review 6.  Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis.

Authors:  Josef Gotzmann; Mario Mikula; Andreas Eger; Rolf Schulte-Hermann; Roland Foisner; Hartmut Beug; Wolfgang Mikulits
Journal:  Mutat Res       Date:  2004-01       Impact factor: 2.433

7.  Correlation of Snail expression with histological grade and lymph node status in breast carcinomas.

Authors:  Maria J Blanco; Gema Moreno-Bueno; David Sarrio; Annamaria Locascio; Amparo Cano; José Palacios; M Angela Nieto
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

8.  Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.

Authors:  Andrea Rosner; Keiko Miyoshi; Esther Landesman-Bollag; Xin Xu; David C Seldin; Amy R Moser; Carol L MacLeod; G Shyamala; Amy E Gillgrass; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

9.  Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.

Authors:  Jeannie E Maglione; Erik T McGoldrick; Lawrence J T Young; Ruria Namba; Jeffrey P Gregg; Lin Liu; Drew Moghanaki; Lesley G Ellies; Alexander D Borowsky; Robert D Cardiff; Carol L MacLeod
Journal:  Mol Cancer Ther       Date:  2004-08       Impact factor: 6.261

10.  Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin.

Authors:  Katayoun Alavi Jessen; Stephenie Y Liu; Clifford G Tepper; Juliana Karrim; Erik T McGoldrick; Andrea Rosner; Robert J Munn; Lawrence J T Young; Alexander D Borowsky; Robert D Cardiff; Jeffrey P Gregg
Journal:  Breast Cancer Res       Date:  2004-02-25       Impact factor: 6.466

View more
  37 in total

Review 1.  Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.

Authors:  Tony Blick; Honor Hugo; Edwin Widodo; Mark Waltham; Cletus Pinto; Sendurai A Mani; Robert A Weinberg; Richard M Neve; Marc E Lenburg; Erik W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-06-04       Impact factor: 2.673

Review 2.  Biomarkers for epithelial-mesenchymal transitions.

Authors:  Michael Zeisberg; Eric G Neilson
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

3.  Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

Authors:  Zhe Jiang; Tao Deng; Robert Jones; Huiqin Li; Jason I Herschkowitz; Jeff C Liu; Victor J Weigman; Ming-Sound Tsao; Timothy F Lane; Charles M Perou; Eldad Zacksenhaus
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

4.  Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells.

Authors:  Malgorzata Klauzinska; Bolormaa Baljinnyam; Ahmed Raafat; Jaime Rodriguez-Canales; Luigi Strizzi; Yoshimi Endo Greer; Jeffrey S Rubin; Robert Callahan
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

Review 5.  Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.

Authors:  Chad J Creighton; Jenny C Chang; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-03-31       Impact factor: 2.673

6.  RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.

Authors:  Robert A Jones; Tyler J Robinson; Jeff C Liu; Mariusz Shrestha; Veronique Voisin; YoungJun Ju; Philip E D Chung; Giovanna Pellecchia; Victoria L Fell; SooIn Bae; Lakshmi Muthuswamy; Alessandro Datti; Sean E Egan; Zhe Jiang; Gustavo Leone; Gary D Bader; Aaron Schimmer; Eldad Zacksenhaus
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

Review 7.  Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.

Authors:  Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-29       Impact factor: 2.673

Review 8.  Epithelial to mesenchymal transition and breast cancer.

Authors:  Eva Tomaskovic-Crook; Erik W Thompson; Jean Paul Thiery
Journal:  Breast Cancer Res       Date:  2009-11-09       Impact factor: 6.466

Review 9.  The pathology of EMT in mouse mammary tumorigenesis.

Authors:  Robert Darrell Cardiff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-06-04       Impact factor: 2.673

10.  Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.

Authors:  Marisa G Ponzo; Robert Lesurf; Stephanie Petkiewicz; Frances P O'Malley; Dushanthi Pinnaduwage; Irene L Andrulis; Shelley B Bull; Naila Chughtai; Dongmei Zuo; Margarita Souleimanova; David Germain; Atilla Omeroglu; Robert D Cardiff; Michael Hallett; Morag Park
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.